Improving the reproducibility of the NAP1/B1/027 epidemic strain R20291 in the hamster model of infection

Michelle L Kelly1, Yen Kuan Ng1, Stephen T Cartman2

  • 1Clostridia Research Group, BBSRC/EPSRC Synthetic Biology Research Centre (SBRC), School of Life Sciences, Centre for Biomolecular Sciences, University of Nottingham, University Park, Nottingham, NG7 2RD, United Kingdom.

Anaerobe
|March 7, 2016
PubMed

Insights

Genome engineering created a Clostridium difficile control strain (CRG20291) to accurately study ClosTron mutants. This resolves issues with clindamycin susceptibility in parent strains, enabling reliable virulence assays.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Bacterial Genetics

Background:

  • Clostridium difficile (C. diff) infection is a significant healthcare concern.
  • The BI/NAP1/027 strain R20291 is a hypervirulent C. diff strain.
  • ClosTron-derived ermB mutants are used to study C. diff virulence but are affected by parent strain clindamycin susceptibility.

Purpose of the Study:

  • To develop a suitable control strain for C. diff virulence assays.
  • To overcome limitations posed by clindamycin susceptibility in parent strains.
  • To enable accurate assessment of ClosTron mutant virulence.

Main Methods:

  • Comparative analysis of C. diff strain R20291 and ClosTron-derived ermB mutants.
  • Utilizing genome engineering to create a modified strain.
  • Employing the hamster infection model for virulence assays.

Main Results:

  • The parent strain's clindamycin susceptibility compromised comparative analysis.
  • ClosTron mutants initially appeared more virulent due to this anomaly.
  • A genome-engineered variant (CRG20291) was successfully created.

Conclusions:

  • The engineered CRG20291 strain serves as an ideal control for C. diff virulence studies.
  • This resolves the anomaly caused by clindamycin susceptibility.
  • Facilitates more reliable and accurate research on C. diff pathogenesis.

Related Concept Videos